CA1158161A - Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent - Google Patents

Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent

Info

Publication number
CA1158161A
CA1158161A CA000367043A CA367043A CA1158161A CA 1158161 A CA1158161 A CA 1158161A CA 000367043 A CA000367043 A CA 000367043A CA 367043 A CA367043 A CA 367043A CA 1158161 A CA1158161 A CA 1158161A
Authority
CA
Canada
Prior art keywords
glycerol
ether
lower alkyl
dimethyl ether
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000367043A
Other languages
English (en)
French (fr)
Inventor
Georges Hirth
Walter Boguth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1158161A publication Critical patent/CA1158161A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000367043A 1980-02-07 1980-12-18 Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent Expired CA1158161A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH98380 1980-02-07
CH983/80 1980-02-07

Publications (1)

Publication Number Publication Date
CA1158161A true CA1158161A (en) 1983-12-06

Family

ID=4199742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000367043A Expired CA1158161A (en) 1980-02-07 1980-12-18 Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent

Country Status (17)

Country Link
US (3) US4339447A (enExample)
EP (1) EP0035132B1 (enExample)
JP (1) JPS56125316A (enExample)
AR (1) AR226334A1 (enExample)
AU (1) AU6676481A (enExample)
CA (1) CA1158161A (enExample)
DE (1) DE3170972D1 (enExample)
DK (1) DK47681A (enExample)
FI (1) FI803846L (enExample)
GR (1) GR70308B (enExample)
IE (1) IE810231L (enExample)
IL (1) IL62041A0 (enExample)
MC (1) MC1371A1 (enExample)
NO (1) NO810422L (enExample)
NZ (1) NZ196153A (enExample)
PH (1) PH17121A (enExample)
ZA (1) ZA81650B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
GB8432542D0 (en) * 1984-12-21 1985-02-06 Micropore International Ltd Power control arrangement
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition
US20110038899A1 (en) * 2008-03-28 2011-02-17 Garry Thomas Gwozdz Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1752305A (en) * 1925-04-21 1930-04-01 Winthrop Chem Co Solution of medicament and process of preparing same
DE2038107A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Fluessige,gegebenenfalls als Wasch- oder Reinigungsmittel brauchbare stabilisierte Enzympraeparate
DE2058820A1 (de) 1970-11-30 1972-05-31 Siempelkamp Gmbh & Co Verfahren und Einrichtung zum Herstellen von Holzwerkstoffplatten
DE2252637C3 (de) * 1972-10-26 1979-07-19 Klinge Pharma Gmbh & Co, 8000 Muenchen Verwendung von 1,3-Glycerindiäthern
DE2708419C3 (de) 1977-02-26 1979-08-16 Basf Ag, 6700 Ludwigshafen Verwendung von 1,2-Butandiol-lmethyläther als Lösungsmittel für pharmazeutische Injektionslösungen

Also Published As

Publication number Publication date
AU6676481A (en) 1981-08-13
FI803846A7 (fi) 1981-08-08
IE810231L (en) 1981-08-07
JPS56125316A (en) 1981-10-01
AR226334A1 (es) 1982-06-30
DK47681A (da) 1981-08-08
MC1371A1 (fr) 1982-01-19
US4393057A (en) 1983-07-12
GR70308B (enExample) 1982-09-08
EP0035132A3 (en) 1982-09-29
FI803846L (fi) 1981-08-08
EP0035132A2 (de) 1981-09-09
US4339447A (en) 1982-07-13
IL62041A0 (en) 1981-03-31
EP0035132B1 (de) 1985-06-19
PH17121A (en) 1984-06-01
NZ196153A (en) 1983-07-29
US4393073A (en) 1983-07-12
NO810422L (no) 1981-08-10
ZA81650B (en) 1982-03-31
DE3170972D1 (en) 1985-07-25

Similar Documents

Publication Publication Date Title
US4734284A (en) Etoposide preparations
US5563177A (en) Taste masking guaifenesin containing liquids
KR100258423B1 (ko) 오메프라졸 및 그의 동족체를 함유하는 주사제 및 주사제 키트
EP0309157B1 (en) Sustained release etodolac
JPS61194034A (ja) 経鼻投与用粉末状組成物
KR850004392A (ko) 경구투여용 장기작용 약제의 제조방법 및 조성물
IE862869L (en) Effervescent composition
HU195918B (en) Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
AU5909498A (en) Formulations for amylin agonist peptides
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
JP2002356420A (ja) 安定な水性液剤
CA1158161A (en) Pharmaceutical preparation containing a glycerol lower alkyl ether as solvent
KR980700872A (ko) 경점막 투여용 제제(transmucosal preparation)
US4696814A (en) Parenteral phenytoin compositions
JPH0214058B2 (enExample)
US4303643A (en) Sulfonamide compositions
JPS639493B2 (enExample)
EP1156829B1 (fr) Formulation stable contenant de la fumagilline
US2888381A (en) Solutions of citrus bioflavonoids
JP2002193837A (ja) テルペンアルコールエトキシル化物の化粧品もしくは医薬品または食品用濃縮物に加える可溶化剤としての使用
CN100391447C (zh) 一种辅酶q10冻干粉针剂及其制备方法
GB2185887A (en) Temazepam composition
JPH1135489A (ja) ポリオキシエチレン硬化ヒマシ油類の分解を防止した液剤
GB1593354A (en) Liquid pharmaceutical formulations
EP0021847B1 (en) Long acting sulfonamide injectable compositions

Legal Events

Date Code Title Description
MKEX Expiry